Company
Verastem, Inc.
Verastem, Inc. has 1 drug tracked on RxWires: 1 in Phase 1/2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Pembrolizumab | Phase 1/2 | Pancreatic Ductal Adenocarcinoma |
Latest
No recent events.
Follow Verastem, Inc. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.